Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Nissan Chemical Corporation is developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.
Work with MIT Reactor (MITR) scientists on real-time imaging of lithium-ion battery cells, binder removal from ceramic stereolithography green bodies, or analysis of hydrogen retention in irradiated metallic hydrides. To get started, contact Dr. Boris Khaykovich at bkh@mit.edu or 617.253.2681.
Select startups to explore opportunities such as joint development, proof of concept and pilot with the company.
Procter & Gamble seeks to leverage GenAI technologies to transform the future of commerce by enhancing consumer experiences, improving selling operations, and optimizing retail execution.